In summary, our results show that a conditional modulator of protein kinase activity such as INR119 may use the ROS generated by ERK signalling to enhance its kinase activity and increase the expression of proapoptotic genes such as TP53 and BAX, further elevating the cancer-cell killing effect. Here, TP53 is linked to cancer.